FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

TURNER CARLTON E DR 		2. Issuer Name and Ticker or Trading Symbol

TUTOGEN MEDICAL INC [ TTG ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

2001 WALNUT HILL LANE 		3. Date of Earliest Transaction (MM/DD/YYYY)

1/23/2007
(Street)

IRVING, TX 75038
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

2/1/2007 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   1/23/2007   (1)   M    8000   A $4.4   18000   D    
Common Stock   1/23/2007   (1)   S    8000   D $6.8   10000   D    
Common Stock   1/25/2007   (1)   M    2000   A $4.4   12000   D    
Common Stock   1/25/2007   (1)   M    2000   A $2.71   14000   D    
Common Stock   1/25/2007   (1)   S    2800   D $6.4   11200   D    
Common Stock   1/25/2007   (1)   S    1200   D $6.45   10000   D    
Common Stock   1/26/2007   (1)   M    3900   A $2.71   13900   D    
Common Stock   1/26/2007   (1)   S    200   D $6.46   13700   D    
Common Stock   1/26/2007   (1)   S    1800   D $6.4   11900   D    
Common Stock   1/26/2007   (1)   S    1900   D $6.48   10000   D    
Common Stock   1/29/2007   (1)   M    2100   A $2.71   12100   D    
Common Stock   1/29/2007   (1)   S    2100   D $6.4   10000   D    
Common Stock   1/30/2007   (1)   M    2000   A $2.71   12000   D    
Common Stock   1/30/2007   (1)   M    10000   A $3.62   22000   D    
Common Stock   1/30/2007   (1)   M    2500   A $2.46   24500   D    
Common Stock   2/15/2007   (1)   S    5800   D $7.4   18700   D    
Common Stock   2/15/2007   (1)   S    5200   A $7.5   13500   D    
Common Stock   2/15/2007   (1)   S    1000   A $7.52   12500   D    
Common Stock   2/15/2007   (1)   S    100   D $7.56   12400   D    
Common Stock   2/15/2007   (1)   S    400   D $7.61   12000   D    
Common Stock   2/15/2007   (1)   S    1000   D $7.68   11000   D    
Common Stock   2/15/2007   (1)   S    1000   D $7.74   10000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director's Stock Option (Right to Buy)   $4.4   (2) 1/23/2007     M        8000    4/9/2002   4/9/2012   Common Stock   8000   $0   0   D    
Director's Stock Option (Right to Buy)   $4.4   (2) 1/25/2007     M        2000    4/9/2002   4/9/2012   Common Stock   2000   $0   0   D    
Director's Stock Option (Right to Buy)   $2.71   (2) 1/25/2007     M        2000    4/8/2003   4/8/2013   Common Stock   2000   $0   0   D    
Director's Stock Option (Right to Buy)   $2.71   (2) 1/26/2007     M        3900    4/8/2003   4/8/2013   Common Stock   3900   $0   0   D    
Director's Stock Option (Right to Buy)   $2.71   (2) 1/29/2007     M        2100    4/8/2003   4/8/2013   Common Stock   2100   $0   0   D    
Director's Stock Option (Right to Buy)   $2.71   (2) 1/30/2007     M        2000    4/8/2003   4/8/2013   Common Stock   2000   $0   0   D    
Director's Stock Option (Right to Buy)   $3.62   (2) 1/30/2007     M        10000    8/6/2004   8/6/2014   Common Stock   10000   $0   0   D    
Director's Stock Option (Right to Buy)   $2.46   (2) 1/30/2007     M        2500    3/14/2005   3/14/2015   Common Stock   2500   $0   0   D    

Explanation of Responses:
( 1)  On February 1, 2007, the reporting person filed a Form 4 that incorrectly reported the transaction date, deemed execution date, transaction code, number of securities either acquired or disposed of and amount of securities beneficially owned following the transaction, all for his (i) cashless exercise of Director's Stock Options, with an aggregate of 18,000 shares of common stock underlying such options, on January 23, 2007, January 25, 2007, January 26, 2007 and January 29, 2007, (ii) exercise of Director's Stock Options to buy an aggregate of 14,500 shares of underlying common stock on January 30, 2007 and (iii) sale of 14,500 shares of common stock on February 15, 2007. Each such transaction reported by the reporting person is incorrectly reported and restated by the transactions reported herein.
( 2)  On February 1, 2007, the reporting person filed a Form 4 that incorrectly reported the exercise price of the derivative security, transaction date, deemed execution date, number of derivative securities disposed of, date exercisable, expiration date, amount of shares underlying the securities, price of the derivative security and number of derivative securities beneficially owned following the reported transaction, all for his (i) cashless exercise of Director's Stock Options, with an aggregate of 18,000 shares of common stock underlying such options, on January 23, 2007, January 25, 2007, January 26, 2007 and January 29, 2007 and (ii) exercise of Director's Stock Options to buy an aggregate of 14,500 shares of underlying common stock on January 30, 2007. Each such transaction reported by the reporting person is incorrectly reported and restated by the transactions reported herein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
TURNER CARLTON E DR
2001 WALNUT HILL LANE
IRVING, TX 75038 		X



Signatures
/s/ CARLTON E TURNER 12/14/2007
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Tutogen Medical (AMEX:TTG)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Tutogen Medical.
Tutogen Medical (AMEX:TTG)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Tutogen Medical.